Daniel Sauerstrom

Daniel Sauerstrom

Auto-generated profile, based on publicly available information

Daniel Sauerstrom

Principal Scientist, Quality Control, United Therapeutics Corporation, Research Triangle Park

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
MSMargaret R. Sketch
Margaret R. Sketch
DSDaniel Sauerstrom
Daniel Sauerstrom
ALAllison Marie Lange
Allison Marie Lange
JDJane Hall Diehl
Jane Hall Diehl
Background The Remunity Pump for Remodulin (treprostinil) Injection is an infusion system indicated for use with subcutaneous treprostinil. Objective The objective was to assess the stability of diluted treprostinil sodium stored in Remunity pump cassettes. Methods Treprostinil’s chemical and physical stability were assessed over a 76-hour period at 40 degrees Celsius and 75% relative humidity after dilution to 0.01 mg/mL in sterile water for injection and 0.9% sodium chloride. Analyses were conducted via visual inspection, pH measurement, and a stability-indicating high-performance liquid chromatographic assay. Results At all time points, the treprostinil samples were consistently clear, colorless, and free of visible particulate matter, with pH levels 6.0-7.0. All assays were within 90.0%-110.0% of the label claim, with minimal variation. Conclusions Treprostinil diluted to 0.01 mg/mL was stable in Remunity pump cassettes for up to 76 hours at elevated temperature and humidity. No notable changes from label claim concentration values were observed.